 |
市场调查报告书
商品编码
1983183
克隆氏症治疗市场：按地区划分（北美、拉丁美洲、欧洲、亚太地区、中东和非洲）Crohn's Disease Treatment Market, North America, Latin America, Europe, Asia Pacific, Middle East, Africa, By Geography |
||||||
预计到 2026 年，克隆氏症治疗市场规模将达到 128.7 亿美元，到 2033 年将达到 171.6 亿美元。预计从 2026 年到 2033 年，该市场将以 4.2% 的复合年增长率成长。
| 分析范围 | 分析详情 | ||
|---|---|---|---|
| 基准年 | 2025 | 市场规模（2026 年） | 128.7亿美元 |
| 效能数据 | 2020-2024 | 预测期 | 2026-2033 |
| 预测期（2025-2032 年）复合年增长率 | 4.20% | 预计金额（2033 年） | 171.6亿美元 |
克隆氏症是一种慢性发炎性肠道疾病（IBD），会导致消化道发炎。这种发炎可发生于小肠的任何部位，从髂骨到大肠，包括结肠。克隆氏症的常见症状，从轻微到严重不等，包括腹痛、食慾不振、发烧和频繁腹泻。少数情况下，由于肛管发炎引起的撕裂伤，可能会出现直肠出血。克隆氏症的发病因素包括遗传因素、引发发炎的自体免疫反应以及细菌和病毒等环境因素。此病主要影响15至35岁的族群，男女均可患病。
虽然目前尚无针对克隆氏症的特效疗法，但患者可以选择多种治疗方法，以缓解症状并达到长期缓解。包括抗发炎药物、免疫抑制剂、抗生素以及其他用于治疗克隆氏症的抗发炎药物在内的多种药物疗法，可以改善长期预后。
市场动态
在北美和欧洲，发炎性肠道疾病（IBD，例如克隆氏症）的盛行率很高，预计这将推动市场成长。例如，根据2020年12月发表在学术期刊《消化医学研究》（Digestive Medicine Research）上的报导，预计到2030年，北美IBD的患病人数将达到约400万。同一资讯来源的数据也显示，2018年加拿大IBD的盛行率为每10万人725例，预计到2030年将增加至981例。因此，IBD盛行率的上升预计将在预测期内推动市场成长。
本报告的主要特点
- 本报告对全球克隆氏症治疗市场进行了详细分析，包括预测期（2025-2032 年）的市场规模和复合年增长率，以 2024 年为基准年。
- 此外，它还确定了每个细分市场的潜在商机，并描述了该市场中一系列有吸引力的投资提案。
- 此外，它还提供了有关市场驱动因素和限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
- 本节根据以下参数，对全球克隆氏症治疗市场的主要企业进行介绍：公司概况、产品系列、主要亮点、财务表现和策略。
- 本报告中的见解将使负责人和企业经营团队能够就未来的产品发布、产品线更新、市场扩张和行销策略做出明智的决策。
- 《全球克隆氏症治疗市场》报告面向该行业的众多相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
- 相关人员可以透过分析全球克隆氏症治疗市场中使用的各种策略矩阵来促进决策。
目录
第一章：分析目标与假设
- 分析目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章：市场动态、监管与趋势分析
- 市场动态
- 促进因素
- 阻碍因素
- 市场机会
- 影响分析
- 主要亮点
- 市场趋势
- 波特五力分析
- 流行病学
- 新产品发布
- 创新：按产品类型划分
第四章：全球克隆氏症治疗市场：依药物类型划分（2026-2033 年）
- 概述
- 抗生素
- 氨基水杨酸类药物
- 皮质类固醇
- 免疫调节药物
- 其他的
第五章：全球克隆氏症治疗市场：依通路划分（2026-2033 年）
- 概述
- 医院药房
- 零售药房
- 电子商务
第六章：全球克隆氏症治疗市场：按地区划分（2026-2033 年）
- 北美洲
- 我们
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
- 欧洲
- 英国
- 德国
- 义大利
- 法国
- 西班牙
- 俄罗斯
- 其他欧洲国家
- 亚太地区
- 中国
- 印度
- 日本
- ASEAN
- 澳洲
- 韩国
- 亚太其他地区
- 中东
- GCC
- 以色列
- 其他中东国家
- 非洲
- 北非
- 中非
- 南非
第七章 竞争情势
- AbbVie Inc.
- Janssen Biotech, Inc.
- Bristol-Myers Squibb Company
- Boehringer Ingelheim GmbH
- Pfizer Inc.
- Eli Lilly and Company
- Novartis AG
- Sanofi
- Takeda Pharmaceutical Company Limited
- Mylan NV
- Amgen Inc.
- AstraZeneca
第八章
- 分析方法
- 关于 Coherent Market Insights
Crohn's Disease Treatment Market is estimated to be valued at USD 12.87 Bn in 2026 and is expected to reach USD 17.16 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.2% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 12.87 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.20% | 2033 Value Projection: | USD 17.16 Bn |
Crohn's disease is a form of chronic inflammatory bowel disease (IBD) that causes inflammation in the gastrointestinal tract. This inflammation can take place anywhere between the ileum of the small intestine to the colon of the large intestine. Common symptoms of Crohn's disease from mild to severe intensity include abdominal pain, reduced appetite, fever, and frequent diarrhea. Rectal bleeding is encountered in few cases due to fissures from inflammation at anal canal. Factors responsible for causing Crohn's disease include hereditary genes, autoimmune reaction that causes inflammatory condition, and environmental factors such as bacteria and virus. The disease majorly affects people falling between age group of 15-35 years and occurs in both males and females.
There exists no specific cure for the disease, however various therapies can be employed on patients that can help to reduce signs and symptoms of the disease as well as can bring long-term remission. Improvement in long-term prognosis can be achieved through several medications prescribed for the treatment of Crohn's disease that include anti-inflammatory drugs, immune system suppressers, antibiotics and other medication that helps to control inflammation.
Market Dynamics
The North America and Europe regions have high incidence of inflammatory bowel disease (IBD) such as Crohn's disease, which is expected to drive growth of market. For instance, according to an article published in the journal Digestive Medicine Research in December 2020, in North America, the prevalence of IBD is projected to affect approximately 4 million persons by 2030. According to the same source, data from Canada reported a prevalence of IBD at 725 per 100,000 in 2018, which is estimated to rise to 981 by 2030. Thus the increasing prevalence of IBD is expected to drive market growth over the forecast period.
Key features of the study
- This report provides in-depth analysis of the global crohn's disease treatment market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global crohn's disease treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include AbbVie Inc., Janssen Biotech, Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Pfizer Inc., Eli Lilly and Company, Novartis AG, Sanofi, Takeda Pharmaceutical Company Limited, Mylan N.V., Amgen Inc., and AstraZeneca
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global crohn's disease treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global crohn's disease treatment market
Market Segmentation
- By Drug Type
- Antibiotics
- Amino Salicylates
- Corticosteroids
- Immunomodulators
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- E-Commerce
- By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
- Key Players
- AbbVie Inc.
- Janssen Biotech, Inc.
- Bristol-Myers Squibb Company
- Boehringer Ingelheim GmbH
- Pfizer Inc.
- Eli Lilly and Company
- Novartis AG
- Sanofi
- Takeda Pharmaceutical Company Limited
- Mylan N.V.
- Amgen Inc.
- AstraZeneca
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Highlights
- Market Trends
- PORTER's Five Forces Analysis
- Epidemiology
- New Product Launch
- Product Type Innovation
4. Global Crohn's Disease Treatment Market, By Drug Type, 2026 - 2033, (US$ Billion)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Antibiotics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Amino Salicylates
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Corticosteroids
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Immunomodulators
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
5. Global Crohn's Disease Treatment Market, By Distribution Channel, 2026 - 2033, (US$ Billion)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- E-Commerce
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
6. Global Crohn's Disease Treatment Market, By Region, 2026 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- UK
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (US$ Billion)
- North Africa
- Central Africa
- South Africa
7. Competitive Landscape
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Janssen Biotech, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Boehringer Ingelheim GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
8. Section
- Research Methodology
- About Us
克隆氏症治疗市场：全球市场按治疗方法、给药途径、分销管道和最终用户分類的预测——2026-2032年
全球克隆氏症治疗市场规模、份额、趋势和成长分析报告（2026-2034）
克隆氏症治疗市场－全球产业规模、份额、趋势、机会及预测（依药物类型、应用、通路、地区及竞争格局划分，2021-2031年）
克罗恩病治疗市场
克隆氏症治疗市场规模、份额、趋势分析报告：按类型、给药途径、分销管道、地区、细分市场预测，2024-2030
克罗恩病治疗市场- 按治疗（药物{抗炎药、免疫抑制剂、抗生素、退烧药}、营养治疗、手术）、剂型（口服、肠胃外）、年龄组、最终用途、全球预测2024 - 2032